| 000 | 01309 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511165436.0 | ||
| 264 | 0 | _c19760311 | |
| 008 | 197603s 0 0 eng d | ||
| 022 | _a0069-0112 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaufman, J | |
| 245 | 0 | 0 |
_aClinical phase I trial of inosine dialdehyde (NSC-118994). _h[electronic resource] |
| 260 |
_bCancer chemotherapy reports _c |
||
| 300 |
_a1007-14 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAldehydes _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Marrow Diseases _xchemically induced |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aHematologic Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 |
_aInosine _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMittelman, A | |
| 773 | 0 |
_tCancer chemotherapy reports _gvol. 59 _gno. 5 _gp. 1007-14 |
|
| 999 |
_c1113801 _d1113801 |
||